University of Manchester and CPL Aromas Limited 23_24 R6

A perfume company is building a scientific framework to prove that its fragrances can measurably improve mood and mental focus. The problem is straightforward: many companies sell scents that claim to boost wellbeing, but few have the rigorous, repeatable data to back those claims up. CPL Aromas wants to change that by creating a formal R&D process—called "Aromawellness"—that tests their functional fragrances for specific cognitive and emotional effects, such as reducing stress or sharpening attention. Without this validation, the industry relies on marketing hype rather than evidence. If the framework works, it could transform how scents are used in everyday products. Office air fresheners might be designed to sustain concentration. Hospital waiting rooms could use fragrances that lower patient anxiety. Car interiors or hotel lobbies could be engineered for a particular emotional response. The impact would be invisible but constant—a subtle, background improvement to the environments people occupy daily. This is applied commercial research, not fundamental science. The goal is not to discover new principles of olfaction, but to build a reliable method for turning existing fragrance ingredients into validated wellness tools.